Massimo Libra

26.2k citations
328 papers · 21.4k · 7 hit papers · h-index 74

Impact in

    • MicroRNA in disease regulation
  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • Cancer Cells and Metastasis

Papers in

    • Cancer-related Molecular Pathways 16
    • Viral-associated cancers and disorders 11
    • MicroRNA in disease regulation 18

Massimo Libra

321 papers receiving 20.9k citations

Massimo Libra's Hit Papers

Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 2024 · 657 citations
6570+6+13Years since publication5001k1.5k

Peers

Massimo Libra
Comparison fields: 5 of 175
  • Cancer Research 2.5k
  • Oncology 3.7k
  • Molecular Biology 6.2k
  • Aging 119
  • Hepatology 586
Replace Michele Caraglia with:
Michele Caraglia Italy
Sergei I. Grivennikov United States
Philip R. Taylor United States
Bernard Mark Evers United States
Jian Zhang China
Hua Wang China
Florian R. Greten Germany
Alberto Maria Martelli Italy
Adriana Albini Italy
Demetrios A. Spandidos Greece
Massimo Libra relative to Michele Caraglia Italy Michele Caraglia's profile →
Citations per field
00.5×1.5×
Michele Caraglia · 1×
Citations per year

Countries citing papers authored by Massimo Libra

Since Specialization
Citations

This map shows the geographic impact of Massimo Libra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Libra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Libra more than expected).

Fields of papers citing papers by Massimo Libra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Libra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Libra. The network helps show where Massimo Libra may publish in the future.

Co-authors

The 25 scholars most cited alongside Massimo Libra, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Massimo Libra Line = papers co-authored together Massimo Libra links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 328 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance
Hit paper breakdown →
20061950
2
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
Hit paper breakdown →
2018703
3
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
Hit paper breakdown →
2024675
4
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021
Hit paper breakdown →
2024657
5 2006572
6 2011559
7 2011506
8
Gut Microbiota and Cancer: From Pathogenesis to Therapy
Hit paper breakdown →
2019462
9
Cutaneous melanoma: From pathogenesis to therapy (Review)
Hit paper breakdown →
2018461
10 2014427
11 2008322
12 2015318
13 2012277
14 2012262
15 2013235
16 2017221
17 2011219
18 2020218
19 2014213
20 2008204

About Massimo Libra

Massimo Libra is a scholar working on Oncology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Hepatology, having authored 328 papers that have together received 21.4k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (38 papers), Melanoma and MAPK Pathways (28 papers), Nutritional Studies and Diet (22 papers), Hepatitis C virus research (21 papers), Lymphoma Diagnosis and Treatment (19 papers), MicroRNA in disease regulation (18 papers), Cancer-related Molecular Pathways (16 papers) and Viral-associated cancers and disorders (11 papers). The work is most often cited by research in Cancer Research (2.5k citations), Oncology (3.7k citations), Molecular Biology (6.2k citations), Aging (119 citations) and Hepatology (586 citations). Massimo Libra has collaborated with scholars based in Italy, United States and Greece. Frequent co-authors include Luca Falzone, James Andrew McCubrey, Linda S. Steelman, Alberto Maria Martelli, Saverio Candido, Franca Stivala, Stephen Lee Abrams, Jörg Bäsecke, Ferdinando Nicoletti and Demetrios A. Spandidos. Their work appears in journals such as Oncotarget, Advances in Biological Regulation, International Journal of Oncology, Cell Cycle and International Journal of Molecular Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact